Blackrock Neurotech Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
190
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$200M
- Investors
-
23
Blackrock Neurotech General Information
Description
Developer of a neurotechnology platform designed to record bio-potentials from the central and peripheral nervous system. The company's precision electrode technology is at the core of many worldwide innovations in brain-computer interfaces and neural signal processing and stimulation, helping pioneers walk, talk, see, hear, and feel, enabling the clinical community, with innovative tools and neurotech expertise, to translate technology into novel implantable solutions that improve human lives.
Contact Information
Website
www.blackrockneurotech.comCorporate Office
- 630 Komas Drive
- Suite 200
- Salt Lake City, UT 84108
- United States
Corporate Office
- 630 Komas Drive
- Suite 200
- Salt Lake City, UT 84108
- United States
Blackrock Neurotech Timeline
Blackrock Neurotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC (Series B1) | 29-Apr-2024 | $200M | Completed | Generating Revenue | ||
| 12. Later Stage VC (Series A3) | 31-Jul-2023 | Completed | Generating Revenue | |||
| 11. Debt - PPP | 01-Nov-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 19-May-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | Completed | Generating Revenue | ||||
| 8. Grant | 01-Jun-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 12-Apr-2020 | Completed | Generating Revenue | |||
| 6. Grant | 10-Aug-2019 | Completed | Generating Revenue | |||
| 5. Debt - General | 01-Sep-2018 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Aug-2015 | Completed | Generating Revenue |
Blackrock Neurotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| 2023 Series A -6 | ||||||||
| 2023 Series A -5 | ||||||||
| 2023 Series A -4 | ||||||||
| 2023 Series A -3 | ||||||||
| 2023 Series A -2 | 13,299,308 | $0.000100 | 6% | $0.65 | $0.65 | 1x | $0.65 | 2.13% |
| 2023 Series A -1 | 2,015,100 | $0.000100 | 6% | $1.36 | $1.36 | 1x | $1.36 | 0.32% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Blackrock Neurotech Comparisons
Industry
Financing
Details
Blackrock Neurotech Competitors (5)
One of Blackrock Neurotech’s 5 competitors is EMOTIV, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EMOTIV | Venture Capital-Backed | San Francisco, CA | ||||
| Synchron | Venture Capital-Backed | New York, NY | ||||
| Neurable | Venture Capital-Backed | Boston, MA | ||||
| BrainGate | Venture Capital-Backed | Providence, RI | ||||
| Neuralink | Venture Capital-Backed | Fremont, CA |
Blackrock Neurotech Patents
Blackrock Neurotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260114785-A1 | Tile-based neural recording and stimulation system | Pending | 29-Oct-2024 | ||
| WO-2026093922-A1 | Tile-based neural recording and stimulation system | Pending | 29-Oct-2024 | ||
| US-20260108735-A1 | Systems and methods for pseudomonophasic brain stimulation | Pending | 23-Oct-2024 | ||
| WO-2026090201-A2 | Systems and methods for pseudomonophasic brain stimulation | Pending | 23-Oct-2024 | ||
| US-20260020806-A1 | Implantable embedded systems and related manufacturing methods | Pending | 18-Jul-2024 | A61B5/293 |
Blackrock Neurotech Signals
Blackrock Neurotech Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Redsalt Capital | Family Office | Minority | ||
| Streamlined Ventures Management | Venture Capital | Minority | ||
| Tether Investments | PE/Buyout | Minority | ||
| 2050 Capital | Venture Capital | Minority | ||
| Forepont Capital Partners | Venture Capital | Minority |
Blackrock Neurotech Investments & Acquisitions (4)
Blackrock Neurotech’s most recent deal was a Seed Round with Phantom Neuro for . The deal was made on 03-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Phantom Neuro | 03-Nov-2022 | Seed Round | Therapeutic Devices | ||
| MindX | 20-Apr-2022 | Merger/Acquisition | Business/Productivity Software | ||
| Phantom Neuro | 25-Mar-2022 | Seed Round | Therapeutic Devices | ||
| BrainGate | 01-Jan-2004 | Merger/Acquisition | Therapeutic Devices |
Blackrock Neurotech Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| BrainGate | Providence, RI | 2000 |
Blackrock Neurotech FAQs
-
When was Blackrock Neurotech founded?
Blackrock Neurotech was founded in 2008.
-
Where is Blackrock Neurotech headquartered?
Blackrock Neurotech is headquartered in Salt Lake City, UT.
-
What is the size of Blackrock Neurotech?
Blackrock Neurotech has 190 total employees.
-
What industry is Blackrock Neurotech in?
Blackrock Neurotech’s primary industry is Therapeutic Devices.
-
Is Blackrock Neurotech a private or public company?
Blackrock Neurotech is a Private company.
-
What is the current valuation of Blackrock Neurotech?
The current valuation of Blackrock Neurotech is .
-
What is Blackrock Neurotech’s current revenue?
The current revenue for Blackrock Neurotech is .
-
How much funding has Blackrock Neurotech raised over time?
Blackrock Neurotech has raised $250M.
-
Who are Blackrock Neurotech’s investors?
Redsalt Capital, Streamlined Ventures Management, Tether Investments, 2050 Capital, and Forepont Capital Partners are 5 of 23 investors who have invested in Blackrock Neurotech.
-
Who are Blackrock Neurotech’s competitors?
EMOTIV, Synchron, Neurable, BrainGate, and Neuralink are competitors of Blackrock Neurotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process